Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix

Last updated: August 12, 2025
Sponsor: Alcon Research
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Presbyopia

Astigmatism

Treatment

Clareon PanOptix Trifocal IOL - Non Toric

Clareon PanOptix Trifocal IOL - Toric

Clareon Vivity IOL - Toric

Clinical Study ID

NCT05796453
ILE632-I001
  • Ages > 18
  • All Genders

Study Summary

The purpose of this Post-Market Clinical Follow-up study is to describe the long-term safety and performance of the Clareon Vivity and Vivity Toric and Clareon PanOptix and PanOptix Toric IOLs.

Eligibility Criteria

Inclusion

Key Inclusion Criteria:

  • Subject or legally authorized representative must be able to understand and sign anapproved Informed Consent Form.

  • Subject must have had bilateral implantation of Clareon Vivity, Clareon VivityToric, Clareon PanOptix, or Clareon PanOptix Toric IOLs between 3-6 months prior toenrollment.

  • Subject must have a documented medical history and required pre-operative baselineinformation available for retrospective data collection.

  • Other protocol-defined inclusion criteria may apply.

Exclusion

Key Exclusion Criteria:

  • Subject is currently participating in another investigational drug or device study.

  • Subject has had corneal refractive surgery after Clareon Vivity, Clareon VivityToric, Clareon PanOptix, or Clareon PanOptix Toric IOL implantation.

  • Subject is pregnant at the time of enrollment.

  • Other protocol-defined exclusion criteria may apply.

Study Design

Total Participants: 470
Treatment Group(s): 4
Primary Treatment: Clareon PanOptix Trifocal IOL - Non Toric
Phase:
Study Start date:
September 19, 2023
Estimated Completion Date:
June 30, 2028

Study Description

Subjects will be recruited from a population that has already undergone lens implantation. Retrospective data will be collected from the pre-operative and surgical visits and any safety outcomes reported prior to enrollment. Prospective data will be collected from time of study enrollment through the Year 3 follow-up visit.

Connect with a study center

  • Centro Oftalmologico Metropolitano

    San Juan, 00921
    Puerto Rico

    Site Not Available

  • Wolstan & Goldberg Eye Associates

    Torrance, California 90505
    United States

    Site Not Available

  • Levenson Eye Associates

    Jacksonville, Florida 32204
    United States

    Site Not Available

  • Eye Surgeons of CNY

    Liverpool, New York 13088
    United States

    Site Not Available

  • Tulsa Ophthalmology

    Tulsa, Oklahoma 74104
    United States

    Site Not Available

  • Chu Eye Institute

    Fort Worth, Texas 76107
    United States

    Site Not Available

  • Contact Alcon Call Center for Trial Locations

    Fort Worth, Texas 76134
    United States

    Site Not Available

  • The Eye Institute of Utah

    Salt Lake City, Utah 84107
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.